Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,526.90
+65.10 (2.64%)
May 30, 2025, 10:17 AM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.02 trillion as of May 29, 2025. Its market cap has increased by 13.37% in one year.
Market Cap
1.02T
Enterprise Value
1.08T
Revenue
122.07B
Ranking
n/a
PE Ratio
50.15
Stock Price
2,526.90
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.02T, an increase of 78.31%. That is a compound annual growth rate of 32.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 1,015.91B | -14.51% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,039.04B |
| Divi's Laboratories | 1,778.11B |
| Cipla | 1,195.71B |
| Apollo Hospitals Enterprise | 1,017.06B |
| Zydus Lifesciences | 923.82B |
| Aurobindo Pharma | 691.85B |
| Alkem Laboratories | 629.63B |
| Fortis Healthcare | 532.21B |